PLUS - 医索

找到约 86 条结果

Neoadjuvant nivolumab plus chemotherapy vschemotherapy in patients with resectable NSCLC4-year update from CheckMate 816

医客学院 - 会议报告集

Amivantamab plus lazertinib vs osimertinib infirst-line EGFR-mutant advanced non-small cell lungcancer(NSCLC)with biomarkers of high-risk diseaseA secondary analysis from the phase 3 MARIPOSA study

医客学院 - 会议报告集

Amivantamab plus lazertinib in atypical EGFR-mutatedadvanced non-small cell lung cancer (NSCLC)Results from CHRYSALIS-2

医客学院 - 会议报告集

A Phase ll Randomized Trial Evaluating ConsolidativeNivolumab in Locally Advanced Non-Small Cell LungCancer Post Neoadjuvant Nivolumab plus Chemotherapyand Concurrent chemoradiotherapy (CA209-7AL)

医客学院 - 会议报告集

Updated results from the Phase 1b2 HERKULES-3 studyERAS-007 plus encorafenib and cetuximab (Ec)inpatients (pts)with EC-naive metastatic BRAF V600Ecolorectal cancer (CRC)

医客学院 - 会议报告集

Overall survival (oS) of phase 3 CodeBreak 300 study ofsotorasib plus panitumumab (soto pani) versus investigator'schoice of therapy for KRAS G12c-mutated metastatic colorectacancer (mCRc)

医客学院 - 会议报告集

Nivolumab plus ipilimumab vs chemotherapy as first-linetreatment for microsatellite instability-highmismatchrepairdeficient metastatic colorectal cancer expandedefficacy analysis from CheckMate 8HW

医客学院 - 会议报告集

Neoadjuvant treatment of lBl310 (anti-CTLA-4 antibody) plus sintilimab(anti-PD.1 antibody) in patients with microsatellite instabilityhighmismatchrepair-deficient colon cancer Results from a randomiz

医客学院 - 会议报告集

LBA73 Pathological complete response (pCR) to durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric and gastroesophageal junction cancer (GC

医客学院 - 会议报告集

Camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and hepatic artery infusion chemotherapy for hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C (TRIPLET) a phase II study

医客学院

今日实时热搜